Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

作者：Kathryn E. Stephenson, Chen Sabrina Tan, Stephen R. Walsh, Andrew J. Hale, Jessica L. Ansel, Diane G. Kanjilal, Kate Jaegle, Lauren Peter, Erica N. Borducchi, Joseph P. Nkolola, Tatenda Makoni, Rachel Fogel, Connor Bradshaw, Anna L. Tyler, Edward T. Moseley, Abishek Chandrashekar, Katherine E. Yanosick, Michael S. Seaman, Kenneth H. Eckels, Rafael A. De La Barrera, Jason Thompson, Peter Dawson, Stephen J. Thomas, Nelson L. Michael, Kayvon Modjarrad, Dan H. Barouch · 发表于：The Lancet Infectious Diseases · 年份：2020 · DOI：10.1016/s1473-3099(20)30085-2 · 被引用次数：58 · 研究领域：Mosquito-borne diseases and control、Viral Infections and Outbreaks Research、Biological Research and Disease Studies